Review Article
Mesenchymal Stem Cells in Renal Fibrosis: The Flame of Cytotherapy
Table 3
Literature summary of AMSC in the antifibrotic process.
| Researcher | Fibrogenic signal pathway involved | Delivery method | Animal model | Heterogeneity | Antifibrotic effect |
| Song et al. [50] | TGF-β1/Smad2/3/7 | Tail vein | Rat UUO | Syngeneic | Yes | Burgos-Silva et al. [89] | Not mentioned | i.p. | AKI and CKI mouse models | Syngeneic | Yes | Donizetti-Oliveira et al. [90] | TGF-β | i.p. | Mouse IRI | Syngeneic | Yes | Zou et al. [91] | PAI-1 | Carotid artery | Unilateral RAS mouse model | Syngeneic | Yes | Iwai et al. [93] | Not mentioned | Renal artery | Rat DCD renal transplantation | Syngeneic | Yes | Eirin et al. [95] | Not mentioned | Renal artery | RAS pig model | Autologous | Yes | Quimby et al. [96] | Not mentioned | i.v. | Cat CKD model | Allogeneic | No | Katsuno et al. [98] | Not mentioned | Renal subcapsule | Folic acid-induced AKI rat model | Xenogeneic (from human) | Yes | Chung et al. [99] | Not mentioned | Tail vein | CsA-induced nephropathy rat model | Xenogeneic (from human) | No | Zhu et al. [100] | TGF-β1/Smad3 | Tail vein | Mouse IRI | Xenogeneic (from human) | Yes |
|
|